{
  "id": 21039320,
  "title": "How Fulgent Genetics delivered 64% gains from undervalued entry",
  "url": "https://urgent.news/2026/11/21/how-fulgent-genetics-delivered-64-gains-from-undervalued-entry",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-21T11:10:07.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/investment-ideas/how-fulgent-genetics-delivered-64-gains-from-undervalued-entry-93CH-5043385"
  },
  "original_language": "en",
  "account": null,
  "summary": "In March 2026, Fulgent Genetics (FLGT) was trading at $15.14 after a 41% monthly decline, prompting many investors to exit. However, InvestingPro's Fair Value analysis revealed a different story, indicating an intrinsic value of $22.58, implying a 49% upside from the entry price. Eight months later, the stock delivered a remarkable 64.13% return, validating the power of comprehensive valuation analysis. Despite continued operational challenges, such as earnings misses and revenue shortfalls, the stock has managed to recover, currently trading at 77.7% of its 52-week high.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}